Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional)

Funder: National Institutes of Health

Due Date: 1/1/2020

Budget: Negotiable

Opportunity: RFA-DA-19-002

The purpose of this Funding Opportunity Announcement is to support the discovery and development of medications to prevent and treat opioid use disorders (OUD) and overdose.

Leave a Reply